Category:Statins

Subcategories

This category has only the following subcategory.

Media in category "Statins"

The following 40 files are in this category, out of 40 total.

• 
  Advlip.jpg 911 × 615; 51 KB
  
• 
  Algorithm for statin-associated myopathy.jpg 810 × 900; 88 KB
  
• 
  Biosynthesis-dielsalder.png 1,523 × 1,602; 77 KB
  
• 
  Biosynthesis-lovd.png 1,442 × 1,177; 60 KB
  
• 
  Cholesterolbiosynthesis.png 1,930 × 2,427; 40 KB
  
• Differential-epigenetic-reprogramming-in-response-to-specific-endocrine-therapies-promotes-ncomms10044-s2.ogv 20 s, 1,344 × 1,024; 15.49 MB
  
• Differential-epigenetic-reprogramming-in-response-to-specific-endocrine-therapies-promotes-ncomms10044-s3.ogv 20 s, 1,344 × 1,024; 12.31 MB
  
• Differential-epigenetic-reprogramming-in-response-to-specific-endocrine-therapies-promotes-ncomms10044-s4.ogv 20 s, 1,344 × 1,024; 10.26 MB
  
• Differential-epigenetic-reprogramming-in-response-to-specific-endocrine-therapies-promotes-ncomms10044-s5.ogv 19 s, 1,344 × 1,024; 18.75 MB
  
• Differential-epigenetic-reprogramming-in-response-to-specific-endocrine-therapies-promotes-ncomms10044-s6.ogv 13 s, 1,344 × 1,024; 10.5 MB
  
• Differential-epigenetic-reprogramming-in-response-to-specific-endocrine-therapies-promotes-ncomms10044-s7.ogv 13 s, 1,344 × 1,024; 9 MB
  
• Differential-epigenetic-reprogramming-in-response-to-specific-endocrine-therapies-promotes-ncomms10044-s8.ogv 13 s, 1,344 × 1,024; 10.57 MB
  
• Differential-epigenetic-reprogramming-in-response-to-specific-endocrine-therapies-promotes-ncomms10044-s9.ogv 13 s, 1,344 × 1,024; 8.86 MB
  
• 
  Estatina final.png 315 × 209; 13 KB
  
• 
  Estatina.png 578 × 174; 17 KB
  
• 
  Fluvastatina Grupo fluorofenil.jpg 468 × 311; 26 KB
  
• 
  HMG-CoA reductase pathway.svg 500 × 911; 16 KB
  
• 
  Metabolic pathway of a typical statin.png 4,762 × 4,757; 221 KB
  
• 
  Metabolizm i eliminacja statyn oraz potencjalne mechanizmy ich interakcji lekowych 2013.png 3,345 × 1,965; 534 KB
  
• 
  Ogólny mechanizm plejotropowego działania statyn.png 3,507 × 2,480; 403 KB
  
• 
  Schematyczna budowa cząsteczki statyn.png 4,877 × 2,170; 109 KB
  
• 
  Statin final.svg 210 × 139; 14 KB
  
• 
  Statin mechanism v01.svg 652 × 282; 65 KB
  
• 
  Statin pharmacophore 2.png 3,787 × 2,861; 63 KB
  
• 
  Statin pharmacophore.png 665 × 614; 7 KB
  
• 
  Statin pharmacophore.svg 162 × 142; 10 KB
  
• 
  Statin Risks (6941350219).jpg 2,784 × 2,702; 1.08 MB
  
• 
  Statin-Test.png 838 × 759; 66 KB
  
• 
  Statin.svg 385 × 116; 17 KB
  
• 
  Statinfamily.png 1,144 × 315; 48 KB
  
• 
  StatinPathway WP430.png 828 × 743; 62 KB
  
• 
  Statins-1.generation v01.svg 988 × 476; 103 KB
  
• 
  Statins77.png 516 × 461; 38 KB
  
• 
  Vectorial pathway for statin distribution from enterocytes to hepatocytes for their pharmacological action and metabolism and elimination via the bile and kidneys.png 3,654 × 2,375; 697 KB
  
• 
  Wpływ fluwastatyny na wskaźniki lipidowe 01.png 1,747 × 1,900; 69 KB
  
• 
  Wpływ fluwastatyny na wskaźniki lipidowe 02.png 1,747 × 1,891; 46 KB
  
• 
  Wpływ fluwastatyny na wskaźniki lipidowe 03.png 1,751 × 1,900; 78 KB
  
• 
  Wpływ prawastatyny na wskaźniki lipidowe 01.png 1,747 × 1,900; 75 KB
  
• 
  Wpływ prawastatyny na wskaźniki lipidowe 02.png 1,747 × 1,891; 77 KB
  
• 
  Wpływ prawastatyny na wskaźniki lipidowe 03.png 1,755 × 1,900; 82 KB